| 1 |
25516145 | CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro. | 2015 Feb |
1 |
| 2 |
26198313 | Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review. | 2015 Oct |
1 |
| 3 |
26507668 | Interethnic differences of cytochrome P450 gene polymorphisms may influence outcome of taxane therapy in Roma and Hungarian populations. | 2015 Dec |
1 |
| 4 |
20632082 | Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients. | 2010 Nov |
4 |
| 5 |
18187806 | Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel. | 2008 Jan |
1 |